People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CytoTronics, Inc. | — | Other Technology | Series A | $13.5M | $83.1M | 2024 |
| BioFlyte, Inc. | — | Other Technology | Series A | $5.4M | $55.4M | 2022 |
Jenna Abelli at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jenna Abelli on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Blivin | 1 | 14 |
| David Seldin | 1 | 11 |
| Bradley Harrison | 1 | 5 |
| SAMEER ROHATGI | 1 | 2 |
| Jeffrey Abbott | 1 | 1 |
| Douglas Kahn | 1 | 1 |
| Wenxuan Wu | 1 | 1 |
| Todd Sickles | 1 | 1 |
| John Bolton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.